References
Bendz H, Aurell M. Drug-induced diabetes insipidus: incidence, prevention and management. Drug Saf 1999; 21 (6): 449–56
Siegel AJ, Baldessarini RJ, Klepser MB, et al. Primary and drug-induced disorders of water homeostasis in psychiatric patients: principles of diagnosis and management. Harv Rev Psych 1998; 6: 190–200
Bendz H, Aurell M, Balldin J, et al. Kidney damage in long-term lithium patients: a cross-sectional study of patients with 15 years or more on lithium. Nephrol Dial Transplant 1994; 9: 1250–4
Boton R, Gaviria M, Batlle DC. Prevalence, pathogenesis and treatment of renal dysfunction associated with chronic lithium therapy. Am J Kidney Dis 1987; 10: 329–45
Batlle DC, von Riotte AB, Gaviria M, et al. Amelioration of polyuria by amiloride in patients receiving long-term lithium therapy. N Engl J Med 1985; 312: 408–14
Giatras I, Lau J, Levey AS. Effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease: a meta-analysis of randomized trials. Ann Intern Med 1997; 127: 337–45
Blayney-Chandramouli J, Stokes JB. Use of ACE inhibitors in diabetic and nondiabetic patients with renal disease. Formulary 1998; 33: 318–40
Rights and permissions
About this article
Cite this article
Drug-induced diabetes insipidus: has its importance been diluted?. Drugs Ther. Perspect 17, 10–12 (2001). https://doi.org/10.2165/00042310-200117100-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-200117100-00003